The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experience.
about
Impact of direct acting antivirals on occurrence and recurrence of hepatocellular carcinoma: Biologically plausible or an epiphenomenon?Hepatitis C Virus and Hepatocellular Carcinoma: A Narrative Review.Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows.Epidemiology and Elimination of HCV-Related Liver Disease
P2860
The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experience.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
The risk of early occurrence a ...... erferon: A Belgian experience.
@en
type
label
The risk of early occurrence a ...... erferon: A Belgian experience.
@en
prefLabel
The risk of early occurrence a ...... erferon: A Belgian experience.
@en
P2093
P2860
P356
P1476
The risk of early occurrence a ...... terferon: A Belgian experience
@en
P2093
C Van Steenkiste
C de Galocsy
F D'Heygere
F Janssens
H Van Vlierberghe
J Decaestecker
P2860
P304
P356
10.1111/JVH.12726
P50
P577
2017-08-03T00:00:00Z